84E-13083-84476
4 vaccinations
3 coded responses
29 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 502 / IA
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
CFH-18193-92318
Child or adolescent in my care · Female · 2022-08-15
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Moderna
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
-
2021-01-11
Survey response — day 14, dose 1MedDRA: Migraine — Feeling: FairFree text: MigraineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-18
-
2021-01-25
Dose 2 — Moderna
- 2021-01-25
-
2021-01-26
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-27
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Headache, Fatigue or tirednessFree text: Swollen glands in armpit of shot armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-03-08
- 2021-04-26
- 2021-07-26
-
2021-11-13
Dose 3 — Moderna
- 2022-01-25
-
2022-09-25
Dose 4 — Pfizer-BioNTech
-
2022-10-28
Survey response — day 28, dose 4MedDRA: No adverse event — Feeling: GoodFree text:MedDRA releases: 2024-11 · check-in free text available
- 2022-10-30
- 2022-11-06
- 2023-03-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Moderna | |
| 2 | 2021-01-25 | Moderna | |
| 3 | 2021-11-13 | Moderna | No |
| 4 | 2022-09-25 | Pfizer-BioNTech | No |
Free text
Release 1 — day 14, dose 1
Symptoms: Migraine
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen glands in armpit of shot arm
Release 12 — day 28, dose 4
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | No adverse event | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release